Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: PLoS One, volume 7, issue 4, e34372 (2012)
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Univ.-Bibliothek Frankfurt am Main
- (when)
-
2012
- Contributor
-
Kieffer, Tara L.
De Meyer, Sandra
Bartels, Doug J.
Sullivan, James C.
Zhang, Eileen Z.
Tigges, Ann
Dierynck, Inge
Spanks, Joan
Dorrian, Jennifer
Jiang, Min
Adiwijaya, Bambang
Ghys, Anne
Beumont, Maria
Kauffman, Robert S.
Adda, Nathalie
Jacobson, Ira M.
Sherman, Kenneth E.
Zeuzem, Stefan
Kwong, Ann D.
Picchio, Gaston
- URN
-
urn:nbn:de:hebis:30:3-242929
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:48 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kieffer, Tara L.
- De Meyer, Sandra
- Bartels, Doug J.
- Sullivan, James C.
- Zhang, Eileen Z.
- Tigges, Ann
- Dierynck, Inge
- Spanks, Joan
- Dorrian, Jennifer
- Jiang, Min
- Adiwijaya, Bambang
- Ghys, Anne
- Beumont, Maria
- Kauffman, Robert S.
- Adda, Nathalie
- Jacobson, Ira M.
- Sherman, Kenneth E.
- Zeuzem, Stefan
- Kwong, Ann D.
- Picchio, Gaston
- Univ.-Bibliothek Frankfurt am Main
Time of origin
- 2012
Other Objects (12)
Current and future treatment options for HCV
IL28B single nucleotide polymorphisms in the treatment of hepatitis C
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Forewarned is forearmed
Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten
Chronische Virushepatitiden : Biologie, Diagnostik und Therapie
Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen
Concise review : interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection
Emerging therapies for the treatment of hepatitis C
Fatigue during treatment for hepatitis C virus : results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection
Perspectives and challenges of interferon-free therapy for chronic hepatitis C
Overcoming the roadblocks in hepatitis C virus infection
Current and future treatment options for HCV
IL28B single nucleotide polymorphisms in the treatment of hepatitis C
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Forewarned is forearmed
Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten
Chronische Virushepatitiden : Biologie, Diagnostik und Therapie
Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen
Concise review : interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection
Emerging therapies for the treatment of hepatitis C
Fatigue during treatment for hepatitis C virus : results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection
Perspectives and challenges of interferon-free therapy for chronic hepatitis C
Overcoming the roadblocks in hepatitis C virus infection
Current and future treatment options for HCV
IL28B single nucleotide polymorphisms in the treatment of hepatitis C
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Forewarned is forearmed
Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten
Chronische Virushepatitiden : Biologie, Diagnostik und Therapie
Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen
Concise review : interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection
Emerging therapies for the treatment of hepatitis C
Fatigue during treatment for hepatitis C virus : results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection
Perspectives and challenges of interferon-free therapy for chronic hepatitis C